000 | 01987nam a22002775i 4500 | ||
---|---|---|---|
001 | 978-3-030-73503-6 | ||
003 | DE-He213 | ||
005 | 20240729133101.0 | ||
007 | cr nn 008mamaa | ||
008 | 210713s2021 sz | s |||| 0|eng d | ||
020 | _a9783030735036 | ||
024 | 7 |
_a10.1007/978-3-030-73503-6 _2doi |
|
100 | 1 |
_aJain, Kewal K. _eauthor. _4aut _4http://id.loc.gov/vocabulary/relators/aut |
|
245 | 1 | 0 |
_aDrug-induced neurological disorders _h[E-Book] |
250 | _a4th ed. | ||
264 | 1 |
_aCham : _bSpringer International Publishing : _bImprint: Springer, _c2021. |
|
520 | _aThis book is a first-of-its kind reference that systematically organizes and describes the adverse effects of drugs on the nervous system. Drug safety is recognized as an important aspect of pharmaceutical companies as well as practice of medicine. Chapters include case reports of adverse effects of drugs that are published as well as reported to drug manufacturers. The book scope is broad as it covers lack of efficacy, drug resistance, drug-disease and drug-drug interactions. This information is used to improve the use of drugs as well as to design better and safer drugs for the future, and is relevant to personalized medicine in trying to match the right drugs to the patients. Drug-induced Neurological Disorders offers a unique approach to this important topic by integrating clinical neurology with pharmacology with a focus on effects of drugs on the nervous system including those used for the treatment of neurological disorders as well systemic diseases. Many adverse effects involve multiple systems of the body and the syndromes with predominant effect on the nervous system are included in this book. | ||
650 | 0 | _aNeurology . | |
650 | 0 |
_aPharmacology. _97400 |
|
650 | 1 | 4 | _aNeurology. |
650 | 2 | 4 |
_aPharmacology. _97400 |
856 |
_u#gotoholdings _yAccess resource |
||
942 | _2NLM | ||
999 |
_c95981 _d95981 |